drugset / Trial / NCT06993038

Adenosine vs Diltiazem for Treatment of SVT in the ED

NCT06993038

Phase 4 Recruiting 20 enrolled Anne E. Zepeski
RandomizedSingle-groupSingle-blindTreatment

Summary

This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.

Timeline

Start
2025-08-01
Primary completion
2027-07
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adenosine Small molecule 6 mg Intravenous
Comparator Adenosine Small molecule 12 mg Intravenous
Comparator Diltiazem Small molecule 0.25 mg/kg Intravenous